Many healthcare professionals (e.g., laboratorians, physicians, physician assistants, pharmacists, nurses and genetic counselors) believe pharmacogenomics (PGx) is essential to personalized medicine; however, many still lack confidence prescribing, dosing, interacting with other healthcare professionals and counseling patients with regard to PGx. This session will explore the current evidence, regulatory, reimbursement and best practice recommendations in PGx testing. Keys to successful implementation and emerging large pharmacogenomics initiatives will be discussed with a focus on contemporary issues in the field.
Clinical Implementation of Pharmacogenomics
Philip Empey, PharmD, PhD, University of Pittsburgh, UPMC, Pittsburg, PA, USA
What’s New in Pharmacogenetics?
Victoria M. Pratt. PhD, Indiana University School of Medicine, Indianapolis, IN, USA
Objectives:
- Recognize the availability of evidence-based PGx resources to inform prescribing.
- Describe the key characteristics of PGx alleles that are recommended for inclusion in clinical testing panels by the AMP.
- Understand successful implementation approaches and barriers to increased PGx clinical testing
Duration: 1.25 hr
Recording Date: November 7, 2019
CME/CMLE credit: 1.25 hr
Last day to purchase course and CE claim credit: December 24, 2022
